Galapagos reported EUR133.18M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
argenx SE 852.2M 369.5M Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
Genmab 5M 1.22M Mar/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
GRIFOLS EUR 878.68M 26.38M Jun/2025
Hikma Pharmaceutical USD 358M 183M Dec/2024
Incyte USD 1.41B 1.21B Jun/2025
Merck EUR 1.96B 132M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sanofi 7.08B 14.54B Jun/2025
UCB 750M 1.66B Dec/2024
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025